Free Trial

Nutex Health (NASDAQ:NUTX) Shares Down 3.8% - What's Next?

Nutex Health logo with Medical background

Shares of Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) fell 3.8% on Friday . The company traded as low as $113.14 and last traded at $113.56. 28,904 shares were traded during mid-day trading, a decline of 51% from the average session volume of 59,506 shares. The stock had previously closed at $117.99.

Analyst Upgrades and Downgrades

Separately, Maxim Group lifted their target price on Nutex Health from $75.00 to $100.00 and gave the stock a "buy" rating in a report on Tuesday, April 8th.

Read Our Latest Research Report on NUTX

Nutex Health Price Performance

The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36. The stock's 50 day moving average price is $83.95 and its two-hundred day moving average price is $53.27. The stock has a market cap of $633.67 million, a price-to-earnings ratio of -12.21 and a beta of 0.27.

Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its quarterly earnings results on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, topping the consensus estimate of ($0.09) by $11.21. The company had revenue of $81.30 million for the quarter, compared to the consensus estimate of $81.13 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Insider Buying and Selling at Nutex Health

In other Nutex Health news, CFO Jon Christian Bates bought 1,000 shares of the company's stock in a transaction dated Tuesday, April 8th. The shares were purchased at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the transaction, the chief financial officer now directly owns 4,888 shares of the company's stock, valued at approximately $399,887.28. The trade was a 25.72 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. 38.52% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Nutex Health

A number of hedge funds have recently bought and sold shares of the business. Bank of America Corp DE raised its stake in shares of Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock worth $66,000 after buying an additional 2,043 shares during the period. Northern Trust Corp acquired a new position in Nutex Health during the fourth quarter worth $200,000. Baader Bank Aktiengesellschaft purchased a new position in Nutex Health during the fourth quarter valued at $206,000. Millennium Management LLC acquired a new stake in shares of Nutex Health in the fourth quarter valued at about $213,000. Finally, World Investment Advisors acquired a new stake in shares of Nutex Health in the fourth quarter valued at about $217,000. Hedge funds and other institutional investors own 5.32% of the company's stock.

Nutex Health Company Profile

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines